Thank you for sharing!

Your article was successfully shared with the contacts you provided.
SAN FRANCISCO — Medical marijuana advocates and federal prosecutors have never agreed on whether the drug has medical value. Now, an Oakland, Calif.-based advocacy group wants a court order that would force the federal government to see it their way. Americans for Safe Access is trying to use a little-known Clinton-era law to make federal agencies take back statements about marijuana — for example, that pot has “no currently accepted medical use.” The group says this “misinformation” costs it time and money to refute. But before the nonprofit can put any experts on the witness stand, it has to overcome a challenge to its standing to sue. The government’s motion to dismiss the case was heard last week before U.S. District Judge William Alsup of the Northern District of California. ASA sued in February under the Information Quality Act. That law calls on federal agencies to maximize the “quality, objectivity, utility and integrity” of information they send out to the public, and it includes an administrative process for people who seek to correct inaccuracies. In 2001 the Drug Enforcement Administration published a statement in the Federal Register saying marijuana has no currently accepted medical use in the United States. ASA, claiming that the government’s position on medical marijuana is “patently false,” petitioned the Department of Health and Human Services, so far unsuccessfully, to correct the statements in its analysis. “Of course courts are going to be leery to jump into the politics of applying science” to public policy, says Davis Wright Tremaine partner Thomas Burke, a San Francisco lawyer who is not working on the case. The First Amendment lawyer notes that if the ASA’s challenge survives the dismissal motion, activists of all stripes who oppose government policies may want to give the strategy a try. In the past Burke has helped sue to force the federal government to release records about “no fly” lists. “The use of the statute would be very important to watch, given all of the headline-grabbing claims that the Bush administration has essentially used politics to trump science,” he notes. To get any satisfaction out of the courts, though, the ASA first has to overcome the government’s standing argument. In court papers, Justice Department attorney Steven Bressler argues that Alsup should dismiss the case because ASA hadn’t identified any members who suffered any harm due to the “allegedly incorrect statement,” and because the group lacks standing to sue on its own behalf. To sue for itself, and not its members, Bressler said the issue in the suit has to be “germane to the plaintiff’s organizational purpose.” He points the court to ASA’s Web site, noting that its mission there was described as “ensur[ing] safe and legal access to cannabis (marijuana) for therapeutic uses and research.” Suing over alleged “misinformation,” he argues, won’t further that goal. “It would not make marijuana use any more (or less) safe. Nor would a correction change the fact that DEA continues to list marijuana as a schedule I [illegal] drug,” he wrote. In an e-mail, Bressler said he wasn’t authorized to discuss the case further outside of court. ASA has countered in its own court papers that its stated purpose is broader, and includes providing medical information to patients, attorneys, health and medical professionals, and policy-makers throughout the United States.
Matthew Hirsch is a reporter for The Recorder , an ALM publication.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.